$70M Novo Nordisk OT Suit Killed By High Court GSK Ruling
A subsidiary of pharmaceutical giant Novo Nordisk A/S escaped a $70 million putative class action Monday after the wage-and-hour suit was dropped in light of the U.S. Supreme Court's decision in...To view the full article, register now.
Already a subscriber? Click here to view full article